BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18431240)

  • 21. Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function.
    Fecci PE; Ochiai H; Mitchell DA; Grossi PM; Sweeney AE; Archer GE; Cummings T; Allison JP; Bigner DD; Sampson JH
    Clin Cancer Res; 2007 Apr; 13(7):2158-67. PubMed ID: 17404100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner.
    Chen J; Schmitt A; Giannopoulos K; Chen B; Rojewski M; Döhner H; Bunjes D; Schmitt M
    Int J Oncol; 2007 Nov; 31(5):1133-9. PubMed ID: 17912440
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defective functions of circulating CD4+CD25+ and CD4+CD25- T cells in patients with chronic ordinary urticaria.
    Chen WC; Chiang BL; Liu HE; Leu SJ; Lee YL
    J Dermatol Sci; 2008 Aug; 51(2):121-30. PubMed ID: 18440785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma conditioning ex vivo generates CD25+CD62L+Foxp3+ regulatory T cells that prevent allograft rejection: potential avenues for cellular therapy.
    Feng G; Wood KJ; Bushell A
    Transplantation; 2008 Aug; 86(4):578-89. PubMed ID: 18724229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficient induction and expansion of human alloantigen-specific CD8 regulatory T cells from naive precursors by CD40-activated B cells.
    Zheng J; Liu Y; Qin G; Chan PL; Mao H; Lam KT; Lewis DB; Lau YL; Tu W
    J Immunol; 2009 Sep; 183(6):3742-50. PubMed ID: 19684082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of mouse CD4(+)CD25(+)Foxp3(+) regulatory T cells in xenogeneic pig thymic grafts.
    Zhang B; Zhang A; Qu Y; Liu J; Niu Z; Zhao Y
    Transpl Immunol; 2009 Jan; 20(3):180-5. PubMed ID: 18845256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. De novo generation and enhanced suppression of human CD4+CD25+ regulatory T cells by retinoic acid.
    Wang J; Huizinga TW; Toes RE
    J Immunol; 2009 Sep; 183(6):4119-26. PubMed ID: 19717521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of functionally preserved CD4+ CD25high regulatory T cells from leukapheresis products from ulcerative colitis patients, applicable to regulatory T-cell transfer therapy.
    Sumida Y; Nakamura K; Kanayama K; Akiho H; Teshima T; Takayanagi R
    Cytotherapy; 2008; 10(7):698-710. PubMed ID: 18985477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE).
    Bonelli M; Savitskaya A; von Dalwigk K; Steiner CW; Aletaha D; Smolen JS; Scheinecker C
    Int Immunol; 2008 Jul; 20(7):861-8. PubMed ID: 18469329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
    Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
    Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a lymphocyte subset displaying a unique regulatory activity in human decidua.
    Amsalem H; Gaiger A; Mizrahi S; Yagel S; Rachmilewitz J
    Int Immunol; 2008 Sep; 20(9):1147-54. PubMed ID: 18628237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of the TCR stimulation strength can render human activated CD4+ T cells suppressive.
    Noël G; Brinster C; Semana G; Bruniquel D
    Int Immunol; 2009 Sep; 21(9):1025-36. PubMed ID: 19625380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro suppression of xenoimmune-mediated macrophage activation by human CD4+CD25+ regulatory T cells.
    Fu Y; Yi S; Wu J; Jimenez E; Simond D; Hawthorne WJ; O'Connell PJ
    Transplantation; 2008 Sep; 86(6):865-74. PubMed ID: 18813112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conversion of peripheral CD4(+)CD25(-) T cells to CD4(+)CD25(+) regulatory T cells by IFN-gamma in patients with Guillain-Barré syndrome.
    Huang S; Li L; Liang S; Wang W
    J Neuroimmunol; 2009 Dec; 217(1-2):80-4. PubMed ID: 19853929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myeloid dendritic cells of patients with chronic HCV infection induce proliferation of regulatory T lymphocytes.
    Dolganiuc A; Paek E; Kodys K; Thomas J; Szabo G
    Gastroenterology; 2008 Dec; 135(6):2119-27. PubMed ID: 18835391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
    Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
    Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoregulatory T cells in the peripheral blood of melanoma patients treated with melanoma antigen-pulsed mature monocyte-derived dendritic cell vaccination.
    Nakai N; Katoh N; Kitagawa T; Ueda E; Takenaka H; Kishimoto S
    J Dermatol Sci; 2009 Apr; 54(1):31-7. PubMed ID: 19157789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expansion of CD4+CD25+ suppressive regulatory T cells from rhesus macaque peripheral blood by FN18/antihuman CD28-coated Dynal beads.
    Gansuvd B; Asiedu CK; Goodwin J; Jargal U; Deckard LA; Andrades P; Guarcello V; Thomas JM
    Hum Immunol; 2007 Jun; 68(6):478-90. PubMed ID: 17509447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of CD25-positive T cells during syngeneic pregnancy: production of stimulatory class II MHC molecules.
    Kyvelidou C; Chatzi K; Semitekolou M; Papathanassiou X; Vassiliadis S; Athanassakis I
    Scand J Immunol; 2009 Dec; 70(6):584-95. PubMed ID: 19906201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.